Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000036.xml
CC BY-NC-ND 4.0 · Laryngorhinootologie 2022; 101(S 01): 103-113
DOI: 10.1055/a-1647-8601
DOI: 10.1055/a-1647-8601
Referat
Patienten relevanter Nutzen und Therapieeffekte in der Stimulationstherapie bei schlafbezogenen Atmungsstörungen
Article in several languages: deutsch | EnglishArmin Steffen
Zusammenfassung
Für die Therapie verschiedener schlafbezogene Erkrankungen und das Schnarchen stehen mittlerweile mehrere Neurostimulationsverfahren zur Verfügung. Zur Behandlung der obstruktiven Schlafapnoe (OSA) existieren überwiegend Daten für die atmungsgesteuerte Hypoglossusnervstimulation (HNS), welche die Senkung der Tagesschläfrigkeit in der Epworth Sleepiness Scale (ESS) in zahlreichen Publikationen übereinstimmend und für mehrere Jahre stabil um gut 5 Punkte zeigen konnte. Die schlafbezogene Lebensqualität im Functional Outcomes of Sleep Questionnaire erbringt in mehreren Kohorten eine Besserung um gut 2 Punkte. Zahlreiche Arbeiten zeigen eine durchschnittliche Nutzung von 5 bis 6 Stunden. Unter Berücksichtigung kürzerer Nachsorgeintervalle und kleinerer Kohorten sinkt der ESS bei der unilateralen kontinuierlichen HNS um 4 und bei der bilateralen um 3 Punkte. Zur Behandlung der zentralen Schlafapnoe ist die transvenöse Stimulation der Nervus phrenicus zugelassen, bei welcher sich in einer Schlüsselstudie mit fünfjähriger Nachbeobachtung der ESS um 3 Punkte gesenkt werden konnte. Die Therapiezeit beträgt in einer Arbeit gut 5 Stunden. Mit der enoralen Stimulationstherapie gegen das Schnarchen konnte der ESS um gut 2 Punkte gesenkt und die schlafbezogene Lebensqualität sowohl des Schnarchenden als auch des Bettpartners gesteigert werden. Die Adhärenz zum täglichen Training für die nächtlichen Effekte wird mit 83% angegeben. Sowohl für die HNS, Phrenicusstimulation als auch die enorale Stimulationstherapie laufen weitere (Register-)Studien bzw. sind angekündigt, welche Patienten relevante Endpunkte berücksichtigen.
Schlüsselwörter
Schlafapnoe - Schnarchen - Patienten-Benefit - Neurostimulation - Hypoglossus - PhrenicusPublication History
Article published online:
23 May 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Stuck BA, Arzt M, Fietze I, Galetke W, Hein H. Heiser et al. Teil-Aktualisierung S3-Leitlinie Schlafbezogene Atmungsstörungen bei Erwachsenen. Somnologie 2020; 24: 176-208
- 2 Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7: 687-698
- 3 Stuck BA, Braumann B, Heiser C, Herzog M, Maurer JT, Plößl S. et al. S3-Leitlinie „Diagnostik und Therapie des Schnarchens des Erwachsenen“ Somnologie. 2019; 23: 178-208
- 4 Stuck BA, Hofauer B. Diagnostik und Therapie des Schnarchens des Erwachsenen. Dtsch Arztebl Int 2019; 116: 817-824
- 5 Arzt M. Update – schlafbezogene Atmungsstörungen. Somnologie 2020; 24: 28-38
- 6 Tschopp S, Wimmer W, Caversaccio M, Borner U, Tschopp KJ. Night-to-night variability in obstructive sleep apnea using peripheral arterial tonometry: a case for multiple night testing. Clin Sleep Med 2021;Ist „online ahead of print“; noch keine Heftnummer etc https://pubmed.ncbi.nlm.nih.gov/33783347/
- 7 Pallansch J, Li Y, Bena J, Wang L, Foldvary-Schaefer N. Patient-Reported Outcomes in Older Adults With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure Therapy. J Clin Sleep Med 2018; 15: 215-222
- 8 Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H. et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007; 30: 711-719
- 9 Institute for Quality and Efficiency in Health Care (IQWiG). Mandibular advancement device in mild to moderate obstructive sleep apnoea in adults: IQWiG Reports – Commission No. N18-03. Institute for Quality and Efficiency in Health Care: Extracts. 2020; 10
- 10 MacKay S, Carney AS, Catcheside PG, Chai-Coetzer CL, Chia M, Cistulli PA. et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA 2020; 324: 1168-1179
- 11 Sommer JU, Heiser C, Gahleitner C, Herr RM, Hörman K, Maurer JT, Stuck BA. Tonsillektomie mit Uvulopalatopharyngoplastik bei obstruktiver Schlafapnoe. Dtsch Arztebl Int 2016; 113: 1-8
- 12 Stuck BA, Ravesloot MJL, Eschenhagen T, de Vet HCW, Sommer JU. Uvulopalatopharyngoplasty with or without tonsillectomy in the treatment of adult obstructive sleep apnea – A systematic review. Sleep Med 2018; 50: 152-165
- 13 Carneiro-Barrera A, Díaz-Román A, Guillén-Riquelme A, Buela-Casal G. Weight loss and lifestyle interventions for obstructive sleep apnoea in adults: Systematic review and meta-analysis. Obes Rev 2019; 20: 750-762
- 14 Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho MP, Erdmann E. et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373: 1095-1105
- 15 Mayer G, Arzt M, Braumann B, Ficker JH, Fietze I, Galetke W. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen, Kapitel „Schlafbezogene Atmungsstörungen bei Erwachsenen“. Somnologie 2017; 20: S97-S180
- 16 Omachi TA. Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). Arthritis Care Res 2011; 63: S287-S296
- 17 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545
- 18 Sauter C, Popp R, Danker-Hopfe H, Büttner A, Wilhelm B, Binder R. et al. Normative values of the German Epworth Sleepiness Scale. Somnologie 2007; 11: 272-278
- 19 Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K. et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997; 20: 835-843
- 20 Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
- 21 Morin CM. Insomnia: Psychological assessment and management. New York: Guilford; 1993
- 22 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001; 2: 297-307
- 23 Gerber M, Lang C, Lemola S, Colledge F, Kalak N, Holsboer-Trachsler E. et al. Validation of the German version of the insomnia severity index in adolescents, young adults and adult workers: results from three cross-sectional studies. BMC Psychiatry 2016; 16: 174
- 24 Strollo PJ, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O. et al. for STAR Trial Group Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014; 370: 139-149
- 25 Doghramji K, Boon MS, Huntley CT, Strohl KP. Upper Airway Stimulation therapy for obstructive sleep apnea – Medical, Surgical and Technical Aspects. New York: Oxford University Press; 2021
- 26 Steffen A, Heiser C, Galetke W, Herkenrath SD, Maurer JT, Eck G. et al. Die Stimulation des Nervus hypoglossus in der Behandlung der obstruktiven Schlafapnoe – Aktualisiertes Positionspapier der Arbeitsgemeinschaft Schlafmedizin der DGHNO-KHC. Laryngorhinootologie 2021; 100: 15-20
- 27 Costantino A, Rinaldi V, Moffa A, Luccarelli V, Bressi F, Cassano M. et al. Hypoglossal nerve stimulation long-term clinical outcomes: a systematic review and meta-analysis. Sleep Breath 2020; 24: 399-411
- 28 Fietze I, Ficker JH, Heiser C, Hofauer B, Schädlich S, Warmuth R. et al. Wenn CPAP nicht genutzt oder nicht vertragen wird – Vorschlag für eine standardisierte Terminologie. Somnologie 2020; 24: 102-105
- 29 Hasselbacher K, Bruchhage KL, Abrams N, Steffen A. Schlafendoskopie und komplett konzentrischer Weichgaumenkollaps bei CPAP-Nutzungsproblemen. HNO 2018; 66: 837-842
- 30 Steffen A, König IR, Baptista PM, Abrams N, Jeschke S, Hasselbacher K. Home Sleep Testing to Direct Upper Airway Stimulation Therapy Optimization for Sleep Apnea. Laryngoscope 2021; 131: E1375-E1379
- 31 Steffen A, Sommer UJ, Maurer JT, Abrams N, Hofauer B, Heiser C. Long-term follow-up of the German post-market study for upper airway stimulation for obstructive sleep apnea. Sleep Breath 2020; 24: 979-984
- 32 Randerath WJ, Galetke W, Domanski U, Weitkunat R, Ruhle KH. Tongue-muscle training by intraoral electrical neurostimulation in patients with obstructive sleep apnea. Sleep 2004; 27: 254-259
- 33 Verse T, Schwalb J, Hörmann K. et al. Submental transcutaneous electrical stimulation for obstructive sleep apnea. HNO 2003; 51: 966-970
- 34 Wiltfang J, Klotz S, Wiltfang J, Jordan W, Cohrs S, Engelbe W. et al. First results on daytime submandibular electrostimulation of suprahyoidal muscles to prevent night-time hypopharyngeal collapse in obstructive sleep apnea syndrome. Int J Oral Maxillofac Surg 1999; 28: 21-25
- 35 Wessolleck BE, Dockter S, Lang S, Sama A, Stuck BA. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie 2018; 22: 47-52
- 36 Kotecha B, Wong PY, Zhang H, Hassaan A. A novel intraoral neuromuscular stimulation device for treating sleep-disordered breathing. Sleep Breath 2021; 1-8 falsch ist „online ahead of print“ noch keine Heftnummer etc. https://pubmed.ncbi.nlm.nih.gov/33772397/
- 37 Baptista PM, Martínez Ruiz de Apodaca P, Carrasco M, Fernandez S, Wong PY, Zhang H. et al. Daytime Neuromuscular Electrical Therapy of Tongue Muscles in Improving Snoring in Individuals with Primary Snoring and Mild Obstructive Sleep Apnea. J Clin Med 2021; 10: 1883
- 38 Woodson BT, Soose RJ, Gillespie MB, Strohl KP, Maurer JT, de Vries N. et al. for STAR Trial Investigators. Three-Year Outcomes of Cranial Nerve Stimulation for Obstructive Sleep Apnea: The STAR Trial. Otolaryngol Head Neck Surg 2016; 154: 181-188
- 39 Gillespie MB, Soose RJ, Woodson BT, Strohl KP, Maurer JT, de Vries N. et al. for STAR Trial Investigators. Upper Airway Stimulation for Obstructive Sleep Apnea: Patient-Reported Outcomes after 48 Months of Follow-up. Otolaryngol Head Neck Surg 2017; 156: 765-771
- 40 Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N. et al. for STAR Trial Investigators. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Otolaryngol Head Neck Surg 2018; 159: 194-202
- 41 Heiser C, Maurer JT, Hofauer B, Sommer JU, Seitz A, Steffen A. Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea in a Multicenter German Postmarket Study. Otolaryngol Head Neck Surg 2017; 156: 378-384
- 42 Steffen A, Sommer JU, Hofauer B, Maurer JT, Hasselbacher K, Heiser C. Outcome after one year of upper airway stimulation for obstructive sleep apnea in a multicenter German post-market study. Laryngoscope 2018; 128: 509-515
- 43 Hasselbacher K, Hofauer B, Maurer JT, Heiser C, Steffen A, Sommer JU. Patient-reported outcome: results of the multicenter German post-market study. Eur Arch Otorhinolaryngol 2018; 275: 1913-1919
- 44 Thaler E, Schwab R, Maurer J, Soose R, Larsen C, Stevens S. et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscope 2019; 130: 1333-1338
- 45 Suurna MV, Steffen Boon M, Chio E, Copper M, Dhanda Patil R. et al. for ADHERE Registry Investigators. Impact of Body Mass Index and Discomfort on Upper Airway Stimulation: ADHERE Registry 2020 Update. Laryngoscope 2021 zur Publikation akzeptiert
- 46 Mehra R, Steffen A, Heiser C, Hofauer B, Withrow K, Doghramji K. et al. Upper airway stimulation versus untreated comparators in positive airway pressure treatment-refractory obstructive sleep apnea. Ann Am Thorac Soc 2020; 17: 1610-1619
- 47 Heiser C, Knopf A, Bas M, Gahleitner C, Hofauer B. Selective upper airway stimulation for obstructive sleep apnea: a single center clinical experience. Eur Arch Otorhinolaryngol 2017; 274: 1727-1734
- 48 Zhu Z, Hofauer B, Wirth M, Heiser C. Long-term changes of stimulation intensities in hypoglossal nerve stimulation. J Clin Sleep Med 2020; 16: 1775-1780
- 49 Huntley C, Kaffenberger T, Doghramji K, Soose R, Boon M. Upper Airway Stimulation for Treatment of Obstructive Sleep Apnea: An Evaluation and Comparison of Outcomes at TwoAcademic Centers. J Clin Sleep Med 2017; 13: 1075-1079
- 50 Steffen A, Baptista P, Ebner E-M, Jeschke S, König IR, Bruchhage K-L. Insomnia impacts on patient-reported outcomes in sleep apnea patients treated with hypoglossal nerve stimulation. In Begutachtung
- 51 Dhanda Patil R, Hong MP, Ishman SL. Hypoglossal nerve stimulation in veterans with comorbid insomnia and sleep apnea. Otolaryngol Head Neck Surg 2021; 164: 1345-1353
- 52 Heiser C, Steffen A, Hofauer B, Mehra R, Strollo PJ, Vanderveken OM. et al. Effect of Upper Airway Stimulation in Patients with Obstructive Sleep Apnea (EFFECT): A Randomized Controlled Crossover Trial. J Clin Med 2021; 10: 2880
- 53 Zhu Z, Hofauer B, Wirth M, Hasselbacher K, Frohnhofen H, Heiser C. et al. Selective upper airway stimulation in older patients. Respir Med 2018; 140: 77-81
- 54 Coca KK, Heiser C, Huntley C, Boon M, de Vries N, Mamidala M, Gillespie MB. Hypoglossal Nerve Stimulation Usage by Therapy Nonresponders. Otolaryngol Head Neck Surg 2021; online ahead of print keine Heftnummer bislang https://pubmed.ncbi.nlm.nih.gov/34372740/1945998211036867
- 55 Friedman M, Jacobowitz O, Hwang MS, Bergler W, Fietze I, Rombaux P. et al. Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: Six-month results. Laryngoscope 2016; 126: 2618-2623
- 56 Mwenge GB, Rombaux P, Dury M, Lengele B, Rodenstein D. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J 2013; 41: 360-367
- 57 Eastwood PR, Barnes M, MacKay SG, Wheatley JR, Hillman DR, Nguyên XL. et al. Bilateral Hypoglossal Nerve Stimulation for Treatment of Adult Obstructive Sleep Apnea. Eur Respir J 2020; 55: 1901320
- 58 Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A. et al. for remedē Pilot Study Investigators. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail 2015; 3: 360-369
- 59 Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R. et al. for remedé System Pivotal Trial Study Group. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lance 2016; 388: 974-982
- 60 Costanzo MR, Javaheri S, Ponikowski P, Oldenburg O, Augostini R, Goldberg LR. et al. for remedē® System Pivotal Trial Study Group. Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes. Nat Sci Sleep 2021; 13: 515-526
- 61 Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR. et al. for remedē® System Pivotal Trial Study Group. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail 2018; 20: 1746-1754
- 62 Schlack R, Hapke U, Maske U, Busch M, Cohrs S. Häufigkeit und Verteilung von Schlafproblemen und Insomnie in der deutschen Erwachsenenbevölkerung. Bundesgesundheitsbl 2013; 56: 740-748
- 63 Sauter C, Dorn H, Danker-Hopfe H. On the influence of the day of the week on objective and self-rated sleep quality of adults. Somnologie 2021; 25: 138-150
- 64 Woehrle H, Graml A, Weinreich G. Therapieadhärenz bei CPAP-Patienten. Somnologie 2010; 14: 135-139
- 65 McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X. et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016; 375: 919-931
- 66 Steffen A, Jeschke S, Soose RJ, Hasselbacher K, König IR. Impulse Configuration in Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea: The Effect of Modifying Pulse Width and Frequency. Neuromodulation 2021; ist online ahead of print keine Heftnummer etc https://pubmed.ncbi.nlm.nih.gov/34214238/
- 67 Hofauer B, Steffen A, Knopf A, Hasselbacher K, Heiser C. Adherence to Upper-Airway Stimulation in the Treatment of OSA. Chest 2018; 153: 574-575
- 68 Pietzsch JB, Richter AK, Randerath W, Steffen A, Liu S, Geisler BP. et al. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting. Respiration 2019; 98: 38-47
- 69 Maurer JT, Perkins J. Einfluss einer afferenten Neurostimulation auf den Tonus des M. genioglossus. Somnologie 2019; 23: S6
- 70 Kent DT, Zealear D, Schwartz AR. Ansa Cervicalis Stimulation: A New Direction in Neurostimulation for OSA. Chest 2021; 159: 1212-1221
- 71 Zhu M, Gong S, Ye J, Wang Y, Peng K. Myoelectric characteristics of tensor palatini and collapsibility of upper airway in OSA patients with different phenotypes under DISE. Eur Arch Otorhinolaryngol 2021.
